DRG: HYBRiD-XL in Kyrgyzstan
Photo (right to left): Jenish Kimsanov, General Manager of URF and Maxi Saenger
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016. He took the chance to visit DRG´s distributor URF in Bishkek.
He was glad to see that URF already has installed 3 DRG:HYBRiD-XLs in this wonderful country in Central Asia. Up to now URF has registerd 28 assays for DRG´s unique automated instrument. At the moment they are in the process to register 6 additional assays, including the new kits Hepcidin 25 (bioactive) and Calprotectin!
Kyrgyzstan´s population is approximately 6 Million. The mountainous country is bordered by Kazakhstan to the north, Tajikistan to the south west, Uzbekistan to the west and China to the east.
DRG:HYBRiD-XL in customer´s lab
[starbox]
News and Updates
BioCheck Inc Acquires DRG International Inc
Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.
Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL
Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level
Cortisol & Adrenal Androgens as Independent Predictors
Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...
